Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL)

Manikhandan A. V. Mudaliar, Ross D. Haggart, Gino Miele, Grant Sellar, Karen A. L. Tan, John R. Goodlad, Elspeth Milne, David M. Vail, Ilene Kurzman, Daniel Crowther, David J. Argyle

    Research output: Contribution to journalArticle

    42 Citations (Scopus)

    Abstract

    We present the first comparison of global transcriptional changes in canine and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the nuclear factor-kappa B (NF-kappaB) pathway. Microarray data generated from canine DLBCL and normal lymph nodes were used for differential expression, co-expression and pathway analyses, and compared with analysis of microarray data from human healthy and DLBCL lymph nodes. The comparisons at gene level were performed by mapping the probesets in canine microarrays to orthologous genes in humans and vice versa. A considerable number of differentially expressed genes between canine lymphoma and healthy lymph node samples were also found differentially expressed between human DLBCL and healthy lymph node samples. Principal component analysis using a literature-derived NF-kappaB target gene set mapped to orthologous canine array probesets and human array probesets clearly separated the healthy and cancer samples in both datasets. The analysis demonstrated that for both human and canine DLBCL there is activation of the NF-kappaB/p65 canonical pathway, indicating that canine lymphoma could be used as a model to study NF-kappaB-targeted therapeutics for human lymphoma. To validate this, tissue arrays were generated for canine and human NHL and immunohistochemistry was employed to assess NF-kappaB activation status. In addition, human and canine B-cell lymphoma lines were assessed for NF-kappaB activity and the effects of NF-kappaB inhibition.

    Original languageEnglish
    Article numbere72591
    Number of pages17
    JournalPLoS ONE
    Volume8
    Issue number9
    DOIs
    Publication statusPublished - 4 Sep 2013

    Fingerprint

    Lymphoma, Large B-Cell, Diffuse
    NF-kappa B
    Gene Expression Profiling
    lymphoma
    Gene expression
    B-lymphocytes
    Canidae
    Chemical activation
    Cells
    gene expression
    dogs
    Microarrays
    Genes
    lymph nodes
    Lymph Nodes
    Lymphoma
    genes
    Principal component analysis
    B-Cell Lymphoma
    Microarray Analysis

    Keywords

    • Animals
    • Blotting, Western
    • Dogs
    • Electrophoretic Mobility Shift Assay
    • Humans
    • Immunohistochemistry
    • Lymphoma, Large B-Cell, Diffuse
    • NF-kappa B
    • Oligonucleotide Array Sequence Analysis
    • Tissue Array Analysis
    • Transcriptome

    Cite this

    Mudaliar, Manikhandan A. V. ; Haggart, Ross D. ; Miele, Gino ; Sellar, Grant ; Tan, Karen A. L. ; Goodlad, John R. ; Milne, Elspeth ; Vail, David M. ; Kurzman, Ilene ; Crowther, Daniel ; Argyle, David J. / Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL). In: PLoS ONE. 2013 ; Vol. 8, No. 9.
    @article{4877b5ce43684526bcc2d9d2601d6120,
    title = "Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL)",
    abstract = "We present the first comparison of global transcriptional changes in canine and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the nuclear factor-kappa B (NF-kappaB) pathway. Microarray data generated from canine DLBCL and normal lymph nodes were used for differential expression, co-expression and pathway analyses, and compared with analysis of microarray data from human healthy and DLBCL lymph nodes. The comparisons at gene level were performed by mapping the probesets in canine microarrays to orthologous genes in humans and vice versa. A considerable number of differentially expressed genes between canine lymphoma and healthy lymph node samples were also found differentially expressed between human DLBCL and healthy lymph node samples. Principal component analysis using a literature-derived NF-kappaB target gene set mapped to orthologous canine array probesets and human array probesets clearly separated the healthy and cancer samples in both datasets. The analysis demonstrated that for both human and canine DLBCL there is activation of the NF-kappaB/p65 canonical pathway, indicating that canine lymphoma could be used as a model to study NF-kappaB-targeted therapeutics for human lymphoma. To validate this, tissue arrays were generated for canine and human NHL and immunohistochemistry was employed to assess NF-kappaB activation status. In addition, human and canine B-cell lymphoma lines were assessed for NF-kappaB activity and the effects of NF-kappaB inhibition.",
    keywords = "Animals, Blotting, Western, Dogs, Electrophoretic Mobility Shift Assay, Humans, Immunohistochemistry, Lymphoma, Large B-Cell, Diffuse, NF-kappa B, Oligonucleotide Array Sequence Analysis, Tissue Array Analysis, Transcriptome",
    author = "Mudaliar, {Manikhandan A. V.} and Haggart, {Ross D.} and Gino Miele and Grant Sellar and Tan, {Karen A. L.} and Goodlad, {John R.} and Elspeth Milne and Vail, {David M.} and Ilene Kurzman and Daniel Crowther and Argyle, {David J.}",
    year = "2013",
    month = "9",
    day = "4",
    doi = "10.1371/journal.pone.0072591",
    language = "English",
    volume = "8",
    journal = "PLoS ONE",
    issn = "1932-6203",
    publisher = "Public Library of Science",
    number = "9",

    }

    Mudaliar, MAV, Haggart, RD, Miele, G, Sellar, G, Tan, KAL, Goodlad, JR, Milne, E, Vail, DM, Kurzman, I, Crowther, D & Argyle, DJ 2013, 'Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL)' PLoS ONE, vol. 8, no. 9, e72591. https://doi.org/10.1371/journal.pone.0072591

    Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL). / Mudaliar, Manikhandan A. V.; Haggart, Ross D.; Miele, Gino; Sellar, Grant; Tan, Karen A. L.; Goodlad, John R.; Milne, Elspeth; Vail, David M.; Kurzman, Ilene; Crowther, Daniel; Argyle, David J.

    In: PLoS ONE, Vol. 8, No. 9, e72591, 04.09.2013.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL)

    AU - Mudaliar, Manikhandan A. V.

    AU - Haggart, Ross D.

    AU - Miele, Gino

    AU - Sellar, Grant

    AU - Tan, Karen A. L.

    AU - Goodlad, John R.

    AU - Milne, Elspeth

    AU - Vail, David M.

    AU - Kurzman, Ilene

    AU - Crowther, Daniel

    AU - Argyle, David J.

    PY - 2013/9/4

    Y1 - 2013/9/4

    N2 - We present the first comparison of global transcriptional changes in canine and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the nuclear factor-kappa B (NF-kappaB) pathway. Microarray data generated from canine DLBCL and normal lymph nodes were used for differential expression, co-expression and pathway analyses, and compared with analysis of microarray data from human healthy and DLBCL lymph nodes. The comparisons at gene level were performed by mapping the probesets in canine microarrays to orthologous genes in humans and vice versa. A considerable number of differentially expressed genes between canine lymphoma and healthy lymph node samples were also found differentially expressed between human DLBCL and healthy lymph node samples. Principal component analysis using a literature-derived NF-kappaB target gene set mapped to orthologous canine array probesets and human array probesets clearly separated the healthy and cancer samples in both datasets. The analysis demonstrated that for both human and canine DLBCL there is activation of the NF-kappaB/p65 canonical pathway, indicating that canine lymphoma could be used as a model to study NF-kappaB-targeted therapeutics for human lymphoma. To validate this, tissue arrays were generated for canine and human NHL and immunohistochemistry was employed to assess NF-kappaB activation status. In addition, human and canine B-cell lymphoma lines were assessed for NF-kappaB activity and the effects of NF-kappaB inhibition.

    AB - We present the first comparison of global transcriptional changes in canine and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the nuclear factor-kappa B (NF-kappaB) pathway. Microarray data generated from canine DLBCL and normal lymph nodes were used for differential expression, co-expression and pathway analyses, and compared with analysis of microarray data from human healthy and DLBCL lymph nodes. The comparisons at gene level were performed by mapping the probesets in canine microarrays to orthologous genes in humans and vice versa. A considerable number of differentially expressed genes between canine lymphoma and healthy lymph node samples were also found differentially expressed between human DLBCL and healthy lymph node samples. Principal component analysis using a literature-derived NF-kappaB target gene set mapped to orthologous canine array probesets and human array probesets clearly separated the healthy and cancer samples in both datasets. The analysis demonstrated that for both human and canine DLBCL there is activation of the NF-kappaB/p65 canonical pathway, indicating that canine lymphoma could be used as a model to study NF-kappaB-targeted therapeutics for human lymphoma. To validate this, tissue arrays were generated for canine and human NHL and immunohistochemistry was employed to assess NF-kappaB activation status. In addition, human and canine B-cell lymphoma lines were assessed for NF-kappaB activity and the effects of NF-kappaB inhibition.

    KW - Animals

    KW - Blotting, Western

    KW - Dogs

    KW - Electrophoretic Mobility Shift Assay

    KW - Humans

    KW - Immunohistochemistry

    KW - Lymphoma, Large B-Cell, Diffuse

    KW - NF-kappa B

    KW - Oligonucleotide Array Sequence Analysis

    KW - Tissue Array Analysis

    KW - Transcriptome

    UR - http://www.scopus.com/inward/record.url?scp=84883403551&partnerID=8YFLogxK

    U2 - 10.1371/journal.pone.0072591

    DO - 10.1371/journal.pone.0072591

    M3 - Article

    VL - 8

    JO - PLoS ONE

    JF - PLoS ONE

    SN - 1932-6203

    IS - 9

    M1 - e72591

    ER -